Recent Articles

Prestigious Commonwealth investment hera...

30 years closer: Children’s Cancer Ins...

Children’s Cancer Institute’s Execut...

Children’s Cancer Institute and Sydney...

Michelle Haber inaugural fellow AAHMS

Deputy Director appointed AM

Zero Childhood Cancer program aims to pu...

A way to target the Achilles heel of neu...

Prime Minister announces major funding c...

Meet our researchers: Prof Maria Kavalla...

Robots play major role in tailoring trea...

Awareness Wednesday: Childhood cancer fa...

Awareness Wednesday: Neuroblastoma

Awareness Wednesday: Leukaemia

Targeting high-risk leukaemia subtypes

Awareness Wednesday: Brain cancers

Children’s Cancer Institute celebrates...

It’s our party: 40 years of research

Professor Maria Kavallaris elected AAHMS...

Skeletons in cancer fight

Four seasons in one lab

$20M from Federal Government for Persona...

We need better treatment for childhood c...

Zero Childhood Cancer program taking sha...

Profiler: what makes cancer cells’ met...

Big data wrangling: Bioinformatics and c...

NSW to become world leader in paediatric...

Nixon's Christmas

An Aussie anti-cancer drug success story

Taking a walk inside a cancer cell

Glowing report: firefly gene shows hidde...

Neuroblastoma treatment search: polyamin...

Meet a Researcher: Q&A with Dr Alvin Kam...

Joining the dots to find neuroblastoma d...

Facts & figures draw a picture of childh...

New leukaemia subtype found by DNA test

How parent's insights help my research

Zero Childhood Cancer update

The microbe that started a revolution

Clinical trials and Lind’s ‘acid tes...

Explainer: what is nanomedicine and how ...

Changing the future for children with br...

Childhood cancers defy current understan...

Sights set on an aggressive childhood le...

Eureka! Prof Michelle Haber a finalist i...

How we’re stopping neuroblastoma’s b...

Meet a scientist keeping drug discovery ...

When I grow up, I want to cure cancer

Awareness Wednesday: Starting with the B...

Awareness Wednesday: Testing our results

Zero Childhood Cancer personalised medic...

Children with most aggressive cancers to...

Awareness Wednesday: going into clinic

Awareness Wednesday: the Future of Child...

How a Dad's Insights can Help Research

Resistance is Futile: The MRP1 Story

Fighting Fund For Brain Cancer Aims To D...

Potential Leukaemia Drug Excites Interna...

We made great strides with childhood leu...

Meet A Researcher: Q&A With Biljana Dume...

How do clinical trials work?

A very techie Christmas

Lexie's Christmas

How specific DNA ‘microdeletions’ he...

VR helps scientists ‘walk’ through c...

Opening doors to a world of scientific e...

Meet a Researcher: Q&A with Dr Marion Le...

It’s in the Delivery: Researchers Find...

Sydney researchers find a way to target ...

Zero Childhood Cancer national clinical ...

Reining In A Runaway Gene In Neuroblasto...

New hope for children's brain cancer

My Daughter's Cancer Journey

Dr Toby Trahair childhood cancer researc...

The past, present and future for young A...

$1 million funding boost for Zero Childh...

My first Mother’s Day without Byron

Neuroblastoma researchers build bridges ...

Forging new alliances to tackle childhoo...

We’ve created our road map for the nex...

Nano-stars – targeting a deadly childh...

Let’s talk about nanomedicine

A global effort to improve childhood can...

Media Release: Prime Minister announces ...

A little girl’s legacy: Olivia Lambert...

Tracking cancer with gold-coated nanopar...

Media Release: 'Zero Childhood Cancer' C...

Awareness Wednesday: Cancer Genomics

Awareness Wednesday: Drug Discovery

Childhood Cancer Awareness Month

New imaging method could help treat and ...

New Drug OBI-3424 An ‘Orphan Drug’ T...

How Targeting Copper Levels in Tumours C...

Partnerships: Cancer Therapeutics CRC

Fundamental mechanism behind chemotherap...

Maria Kavallaris receives Order of Austr...

Australian Scientists Discover a Potenti...

Our researchers combine an old drug with...

Meet new Team Leader, Dr Charles de Bock

World-Class Children's Comprehensive Can...

Dr Angelica Merlot awarded 2019 NSW Youn...

Leading children’s cancer scientist aw...

Childhood cancer scientist rewarded for ...

Endure For A Cure 2019 – The Power Of ...

Minderoo Foundation’s $5 million donat...

Science Spotlight: Leukaemia Stem Cells

New research paves the way for safer leu...

Therapy Developed For Alzheimers Could H...

Anticancer Drug CBL0137 Highly Effective...

Australian researchers find chink in the...

New Gene Found in Neuroblastoma Offers P...

New gene found for a deadly childhood ca...

Our Supporters Turn Out in Record Number...

Children’s Cancer Institute welcome th...

DIPG: Shining A Light On The Deadliest C...

Awareness Wednesday: Immunotherapy

Our New Research Structure

Researchers find new way to target child...

Neuroblastoma research points to new pos...

New therapy shows ‘dramatic’ effect ...

International research collaboration rev...

'Liquid biopsy' - an exciting new test f...

Research boosts progress towards persona...

Children’s cancer researcher awarded N...

An update on our life-saving research

Science spotlight: Metallomics

A message from Professor Michelle Haber

$67m funding collaboration: All Australi...

Diary of a Researcher

Science spotlight: Minimal Residual Dise...

In focus: Brain cancer in kids

Nanomedicine for brain cancer – a worl...

Australia to lead world-first trial in c...

Targeting stem cells: the path to curing...

Executive Director addresses largest can...

Spotlight: Sarcoma in kids

Blocking copper uptake in tumour cells m...

Finding new treatments for those who nee...

Awareness Wednesday: Discover and Transl...

Zero Childhood Cancer: How far have we c...

Leading childhood cancer researcher nomi...

Opening the black box of childhood cance...

'Outstanding' childhood cancer scientist...

Cancer in children – what do the globa...

Cancer research today: Collaboration is ...

Sydney researchers identify/advance pote...

A novel therapeutic approach to MYC-driv...

Celebrating International Women's Day 20...

World-first discovery paves way to new c...

Anya’s Wish: finding new treatments fo...

Australian researchers find new way to t...

Multimodal therapy may hold key to treat...

New drug combination found to be effecti...

In focus: Dr Orazio Vittorio

Funding boost improves outlook for child...

Understanding high-risk leukaemia and ho...

Community funding to help kids with sarc...

Honours scholarship applications now ope...

Improving the outlook for babies with le...

Oncology One announces new drug discover...

Drug discovery in Australia strengthened...

Join us this Childhood Cancer Awareness ...

Professor Maria Kavallaris nominated for...

Fast-tracking new treatments into clinic...

New DNA-based test on the horizon for ch...

‘Moving the dial’ on treatment for c...

Madeleine's Diary of a Researcher

A new age in children’s healthcare for...

Improving the chances for children with ...

Closing the care gap | World Cancer Day ...

Our new virtual lab tour

Cancer Council NSW funds exciting new re...

Celebrating International Women's Day

$185 million investment to fast-track tr...

Minderoo Children’s Comprehensive Canc...

ACRF Launches Liquid Biopsy Program for ...

A personalised approach for children wit...

New treatments for brain cancer – the ...

Professor Michelle Haber elected to dist...

$658M Sydney Children's Hospital and Min...

Genome sequencing provides new path to m...

Childhood cancer researcher recognised f...

Epigenetics: rapidly-evolving areas of r...

Predicting cancer in children: rapidly-e...

Matching treatments to patients: the val...

Immunotherapy for kids with cancer: rapi...

A life should be long | Show your suppor...

Computational biology – harnessing dat...

Inaugural ZERO symposium brings together...
